respiratori
virus
major
caus
morbid
mortal
throughout
world
affect
person
age
addit
million
offic
visit
upper
respiratori
infect
winter
hospit
fill
capac
admiss
due
commun
acquir
pneumonia
acut
exacerb
chronic
obstruct
pulmonari
diseas
asthma
bronchiti
mani
ill
due
viral
infect
pneumonia
influenza
consist
rank
fourth
common
discharg
diagnosi
year
hospit
death
unit
state
attribut
influenza
due
epidem
natur
influenza
rsv
wide
recogn
pathogen
adult
children
respect
howev
true
burden
diseas
contribut
virus
parainfluenza
virus
piv
human
metapneumovirus
hmpv
coronavirus
cov
rhinovirus
hrv
fulli
recogn
use
modern
molecular
detect
method
addit
sensit
rapid
diagnost
test
new
molecular
techniqu
allow
understand
viral
evolut
mechan
predictor
sever
diseas
interrog
vaccin
respons
improv
bacteri
viral
diagnost
associ
viral
infect
nonrespiratori
medic
event
chapter
mani
way
molecular
precis
medicin
impact
field
respiratori
viral
diseas
review
past
defin
epidemiolog
impact
viral
respiratori
pathogen
significantli
hamper
slow
andor
insensit
diagnost
techniqu
cell
cultur
antigen
detect
polymeras
chain
reaction
pcr
revolution
studi
respiratori
virus
provid
extrem
sensit
specif
rapid
mean
detect
fastidi
noncultivat
respiratori
virus
pcr
base
epidemiolog
studi
provid
complet
understand
clinic
spectrum
age
rang
popul
affect
one
studi
convent
method
yield
viral
diagnosi
pneumonia
case
use
pcr
increas
yield
technolog
rapidli
evolv
singleplex
pcr
gel
electrophoresi
multiplex
real
time
assay
product
detect
luminesc
signal
proport
target
amplifi
current
varieti
commerci
avail
assay
detect
viral
respiratori
pathogen
maintain
excel
sensit
mani
clinic
microbiolog
laboratori
move
primarili
molecular
method
viral
detect
pcr
format
becom
increasingli
simpl
nucleic
acid
extract
pcr
fulli
autom
littl
oper
input
molecular
point
care
assay
soon
feasibl
addit
provid
sensit
mean
detect
known
virus
molecular
method
extrem
use
viral
discoveri
past
sever
decad
number
new
respiratori
virus
variant
identifi
includ
hmpv
novel
strain
coronavirus
sarscov
merscov
rhinoviru
c
human
boca
viru
parechovirus
new
strain
avian
influenza
virus
molecular
method
critic
rapid
identif
new
virus
associ
dramat
lethal
outbreak
also
pathogen
discoveri
routin
respiratori
ill
despit
intens
investig
lower
respiratori
ill
pathogen
identifi
suggest
addit
agent
may
yet
discov
sever
differ
genom
approach
pathogen
discoveri
use
success
includ
random
primer
amplif
panvir
dna
microarray
next
gener
sequenc
fig
viral
class
unknown
pathogen
variant
viru
suspect
consensu
pcr
use
degener
primer
detect
sequenc
broadli
conserv
member
group
use
done
identifi
two
new
coronavirus
merscov
anoth
techniqu
viral
discoveri
random
primer
amplif
convent
shotgun
sequenc
pcr
product
case
van
den
hoogen
discov
new
respiratori
viru
young
children
bronchiol
test
neg
rsv
detect
paramyxoviru
like
particl
cell
cultur
rna
subject
random
primer
pcr
viral
sequenc
compar
known
pathogen
new
viru
close
align
avian
pneumoviru
determin
uniqu
human
pathogen
name
human
metapneumoviru
hmpv
similarli
peiri
identifi
novel
coronaviru
caus
sever
acut
respiratori
syndrom
sarscov
use
degeneraterandom
primer
pcr
amplif
use
pan
viral
micro
array
investig
center
diseas
control
prevent
independ
identifi
sarscov
techniqu
random
primer
amplif
pcr
product
hybrid
microarray
consist
oligonucleotid
deriv
everi
fulli
sequenc
viral
genom
hybrid
sequenc
scrape
microspot
amplifi
clone
final
sequenc
identif
complet
novel
infecti
agent
requir
unbias
sequenc
independ
method
univers
amplif
convent
sanger
sequenc
may
poor
sensit
genom
low
quantiti
next
gener
sequenc
ng
involv
analysi
million
sequenc
detect
small
amount
novel
nucleic
acid
sequenc
clinic
sampl
continu
sequenc
assembl
host
sequenc
subtract
residu
sequenc
analyz
similar
known
microbi
sequenc
ng
led
discoveri
numer
novel
human
anim
pathogen
recent
studi
nasopharyng
aspir
thai
children
respiratori
ill
use
ng
identifi
number
mammalian
viral
sequenc
belong
newli
describ
famili
virus
anellovirida
well
novel
strain
hrv
enterovirus
hbov
critic
step
viral
discoveri
avail
bioinformat
tool
effici
identifi
uniqu
viral
sequenc
complex
mixtur
host
bacteri
fungal
sequenc
new
comput
tool
analysi
virom
virusseek
develop
note
detect
equat
causat
discoveri
studi
necessari
infer
associ
genet
antigen
evolut
error
prone
rna
respiratori
virus
particularli
influenza
interest
sever
decad
understand
select
pressur
exert
preexist
immun
viral
evolut
may
help
design
effect
influenza
vaccin
surveil
anim
popul
critic
earli
identif
emerg
influenza
virus
advanc
deep
sequenc
make
possibl
measur
low
frequenc
within
host
viral
divers
factor
antigen
divers
antivir
resist
tissu
specif
studi
understand
complex
viral
evolut
influenza
evolut
popul
level
studi
year
yet
new
antigen
variant
initi
gener
select
level
individu
infect
host
within
host
influenza
virus
exist
swarm
genet
distinct
virus
sanger
sequenc
defin
consensu
sequenc
resolv
minor
variant
viral
popul
deep
sequenc
use
natur
infect
human
challeng
studi
character
within
host
genet
divers
identif
low
frequenc
mutat
hemagglutinin
ha
antigen
site
near
receptorbind
domain
vaccin
unvaccin
influenza
infect
person
highlight
viral
evolut
within
host
due
select
immun
pressur
similarli
ng
reveal
rapid
evolut
drug
resist
variant
therapi
use
sampl
collect
time
mutat
spectrum
influenza
viru
immunocompromis
child
delin
individu
resist
mutat
appear
week
becam
domin
evolv
independ
cocircul
lineag
within
host
evolut
antivir
resist
reflect
combin
frequent
mutat
natur
select
complex
pattern
segment
linkag
reassort
within
host
sequenc
divers
also
examin
infant
sever
combin
immun
defici
persist
rsv
infect
ng
perform
sampl
obtain
bone
marrow
transplant
viral
popul
appear
diversifi
engraft
variat
occur
attach
protein
g
addit
minor
viral
popul
palivizumab
resist
mutat
emerg
administr
deep
sequenc
hrv
human
challeng
studi
shown
hrv
gener
new
variant
rapidli
cours
infect
accumul
chang
hot
spot
capsid
gene
genomewid
associ
studi
gwa
involv
rapidli
scan
set
dna
genom
mani
peopl
find
genet
variat
associ
particular
diseas
typic
genom
case
compar
nonaffect
control
search
singl
nucleotid
polymorph
snp
polygen
chang
associ
risk
protect
suscept
sever
condit
gwa
use
find
genet
variat
risk
asthma
cancer
diabet
heart
diseas
autoimmun
ill
rel
limit
studi
relat
infecti
diseas
recent
studi
examin
host
genet
factor
confer
suscept
respiratori
virus
pandem
influenza
sarscov
rsv
provid
insight
host
genet
factor
respiratori
viral
infect
previous
influenza
research
focus
viral
genet
novel
virus
yet
experi
clearli
indic
host
factor
also
influenc
diseas
sever
number
candid
gene
influenc
respiratori
viru
suscept
identifi
anim
human
studi
involv
host
viru
interact
innat
immun
signal
interferon
relat
pathway
cytokin
respons
tabl
studi
evalu
genet
polymorph
associ
sever
rsv
diseas
none
demonstr
dramat
result
focus
one
candid
gene
result
modestli
increas
odd
ratio
sever
ill
rel
larg
studi
almost
hospit
children
examin
snp
candid
gene
demonstr
suscept
rsv
complex
sever
associ
innat
immun
gene
includ
vitamin
receptor
gene
associ
regul
interleukin
gamma
interferon
nitrou
oxid
synthas
jun
oncogen
import
transcript
regul
innat
immun
pathway
antivir
cytokin
host
transcript
respons
analyz
investig
diseas
pathogenesi
use
varieti
method
includ
invitro
studi
bronchial
epitheli
cell
bec
anim
model
infect
natur
experiment
challeng
addit
two
compart
respiratori
epithelium
blood
sampl
human
studi
interrog
use
differ
virus
viral
strain
develop
gene
signatur
prognosi
indic
sever
identifi
potenti
therapeut
target
respiratori
viral
mechanist
studi
perform
use
influenza
virus
rsv
hrv
coronavirus
use
bec
common
analyz
cellular
respons
use
microarray
common
proinflammatori
cytokin
antigen
present
identifi
although
viral
respons
uniqu
notabl
respons
similar
respons
differ
clinic
isol
rsv
cell
monocyt
deriv
human
macrophag
demonstr
pattern
innat
immun
activ
host
cell
viral
strain
specif
use
rna
seq
differ
note
among
respons
differ
clinic
isol
suggest
differ
rsv
strain
may
vari
inher
virul
human
studi
shown
signific
differ
blood
transcript
profil
chang
time
differ
depend
infect
respiratori
viru
mejia
colleagu
abl
differenti
rsv
hrv
influenza
young
children
base
blood
gene
profil
fig
hrv
infect
exhibit
mildest
innat
adapt
respons
compar
rsv
influenza
neutrophil
gene
express
greatest
rsv
infect
mark
suppress
b
cell
lymphoid
respons
notabl
gene
express
chang
persist
month
infect
similarli
studi
infect
patient
show
transcript
profil
chang
persist
month
transit
innat
adapt
immun
associ
hrv
exacerb
asthma
host
respons
hrv
particular
interest
studi
use
bec
asthmat
healthi
donor
demonstr
differ
transcript
profil
infect
hrv
hrv
similar
picornavirus
induc
gene
express
regul
protein
asthmat
healthi
control
deriv
cell
major
gene
regul
exposur
hrv
howev
signific
express
differ
inflammatori
tumor
suppressor
airway
remodel
metallopeptidas
pathway
note
asthmat
deriv
cell
asymptomat
hrv
infect
quit
common
role
asthma
pathogenesi
question
interestingli
heinonen
et
al
find
differ
blood
transcriptom
asymptomat
hrv
infect
children
compar
noninfect
control
wherea
wesolowskaanderson
colleagu
demonstr
differenti
express
gene
nasal
epithelium
asymptomat
infect
hrv
patient
thu
blood
transcriptom
may
inform
nasal
epitheli
transcript
respons
asymptomat
hrv
infect
given
signific
host
respons
asymptomat
infect
hrv
may
play
role
asthma
exacerb
absenc
clinic
evid
diseas
lastli
may
possibl
identifi
patient
asthma
prone
frequent
hrv
relat
exacerb
examin
gene
express
respons
pbmc
stimul
hrv
gene
express
studi
focus
ill
sever
may
enhanc
understand
diseas
pathogenesi
identifi
potenti
therapi
modul
harm
host
respons
use
develop
biomark
predict
life
threaten
diseas
number
studi
undertaken
understand
pathogenesi
sever
rsv
young
children
identifi
varieti
gene
express
pattern
blood
includ
express
cell
cytotoxicitynk
cell
plasma
cell
gene
well
upregul
jakstat
prolactin
signal
cell
cell
signal
immun
activ
pathway
use
nasal
epitheli
gene
express
analysi
van
den
kieboom
identifi
differenti
express
gene
children
mild
moder
sever
rsv
infect
ubiquitin
tetraspanin
mucin
microseminoprotein
chemokin
ligand
regul
differenti
mild
sever
ill
lastli
nasal
gene
express
complic
interact
nasal
microbiota
host
cell
gene
respons
nasal
sampl
children
rsv
infect
h
influenza
pneumonia
domin
microbiota
toll
like
receptor
neutrophilmacrophag
signal
express
presenc
h
influenza
pneumonia
along
age
sex
predict
risk
hospit
due
rsv
transcript
profil
relat
sever
analyz
season
influenza
well
emerg
avian
pathogen
recognit
diseas
due
infect
novel
viru
nonimmun
host
may
also
due
exagger
host
immun
respons
studi
primarili
season
influenza
influenza
infect
associ
significantli
stronger
antivir
cytokin
attenu
tnk
cell
respons
compar
patient
respiratori
ill
unknown
etiolog
regardless
sever
notabl
ifn
ubiquitin
significantli
regul
sever
vs
mild
moder
diseas
studi
lethal
influenza
vietnam
influenza
viru
macaqu
upregul
key
compon
innat
immun
respons
cell
death
pathway
note
note
infect
regul
earli
regul
inflammasom
like
result
sever
tissu
damag
note
influenza
infect
vitro
anim
human
challeng
studi
use
identifi
new
strategi
control
prevent
symptomat
sever
infect
hrv
challeng
studi
virperin
express
correl
rhinorrhea
chilli
knockdown
express
result
increas
viral
replic
bec
suggest
virperin
antivir
action
might
potenti
therapeut
use
influenza
challeng
studi
clearli
show
defin
transcriptom
profil
blood
prior
onset
symptom
offer
possibl
earlier
effect
oseltamivir
treatment
lastli
host
gene
express
studi
may
allow
investig
link
respiratori
viral
infect
specif
nonrespiratori
event
ampl
epidemiolog
evid
influenza
epidem
link
increas
rate
stroke
myocardi
infarct
mi
increas
rate
fall
function
declin
nurs
home
also
associ
increas
influenza
activ
howev
direct
link
event
viral
infect
scarc
part
due
event
interest
may
follow
infect
sever
week
viru
longer
detect
tradit
test
sever
gene
profil
studi
identifi
viral
infect
signatur
may
persist
post
infect
thu
might
possibl
studi
patient
fall
cardiac
event
evid
recent
viral
infect
use
host
respons
viral
signatur
addit
evalu
host
respons
provid
inform
mechan
diseas
viral
gene
signatur
use
evalu
patient
undergo
cardiac
catheter
notabl
vs
p
viral
gene
signatur
present
vs
without
viral
signatur
suffer
mi
furthermor
infect
patient
show
increas
gene
platelet
express
signatur
provid
insight
infect
may
induc
prothrombot
state
given
avail
rapid
accur
multiplex
pcr
viral
detect
hostbas
diagnost
might
seem
unnecessari
howev
current
pcr
assay
use
conserv
known
viral
sequenc
miss
novel
significantli
mutat
virus
issu
seen
pandem
influenza
pcr
assay
adapt
optim
detect
new
influenza
strain
emerg
novel
respiratori
virus
persist
threat
method
detect
viral
signatur
set
cluster
sever
pneumonia
case
could
use
zaa
colleagu
develop
acut
respiratori
viral
gene
signatur
use
microarray
analysi
blood
volunt
experiment
infect
influenza
hrv
rsv
signatur
subsequ
sensit
specif
classifi
viral
influenza
hrv
infect
patient
present
emerg
room
addit
distinct
blood
transcriptom
signatur
note
patient
sever
pneumonia
upregul
gene
includ
relat
cell
cycl
dna
damag
apoptosi
protein
degrad
helper
cell
regul
gene
primarili
immun
respons
pathway
suggest
immunosuppress
mechan
sever
influenza
pneumonia
investig
develop
gene
classifi
predict
influenza
regardless
concomit
bacteri
infect
predic
could
guid
antivir
therapi
face
neg
pathogen
detect
method
case
respiratori
infect
precis
microbi
etiolog
unknown
antibiot
frequent
administ
empir
although
sensit
molecular
diagnost
pcr
allow
rapid
diagnosi
wide
varieti
respiratori
virus
impact
patient
manag
antibiot
prescript
modest
primarili
due
concern
bacteri
coinfect
approxim
adult
hospit
document
viral
respiratori
infect
evid
concomit
bacteri
infect
thu
clinician
concern
reason
importantli
sensit
specif
diagnost
test
bacteri
lung
infect
current
lack
although
site
infect
respiratori
tract
blood
conveni
sampl
compris
compon
innat
immun
system
neutrophil
natur
killer
cell
well
adapt
immun
system
b
lymphocyt
recent
studi
indic
viral
bacteri
infect
trigger
pathogen
specif
host
transcript
pattern
blood
yield
uniqu
biosignatur
may
discrimin
viral
bacteri
caus
infect
largest
studi
date
tsalik
et
al
use
gene
express
blood
discrimin
bacteri
viral
infect
noninfecti
ill
subject
respiratori
ill
investig
defin
predictor
gene
model
accuraci
discrimin
clinic
adjud
bacteri
viral
noninfecti
ill
studi
date
use
micro
array
recent
rnaseq
use
differenti
viral
bacteri
respiratori
ill
one
studi
gene
note
differenti
express
three
pathway
lymphocyt
acid
metabol
igf
regul
pathway
includ
gene
predictor
bacteri
infect
nonbacteri
infect
auc
nest
cvauc
date
number
gene
express
studi
adult
children
develop
predictor
similar
accuraci
auc
rang
yet
littl
overlap
classifi
gene
identifi
divers
popul
type
infect
plu
altern
analyt
tool
use
like
explain
differ
gene
identifi
work
need
done
refin
predict
gene
set
includ
patient
mix
viralbacteri
respiratori
tract
infect
studi
date
focus
blood
howev
analysi
nasal
respiratori
epithelium
site
infect
might
offer
advantag
although
data
limit
sever
recent
paper
demonstr
nasopharyng
host
respons
also
use
diagnost
respiratori
virus
immun
respons
influenza
vaccin
variabl
influenc
varieti
factor
includ
prior
vaccin
infect
age
presenc
underli
condit
type
vaccin
administ
yet
even
among
rel
homogen
cohort
young
healthi
adult
antibodi
respons
vaccin
variabl
transcript
profil
whole
blood
provid
insight
mechan
variabl
effect
age
vaccin
type
abil
predict
vaccin
respons
baselin
base
transcriptom
signatur
would
signific
clinic
implic
understand
biolog
effect
live
attenu
influenza
vaccin
laiv
compar
trival
inactiv
vaccin
tiv
blood
transcript
profil
young
children
assess
microarray
day
post
vaccin
mani
gene
differenti
express
children
receiv
laiv
compar
tiv
vs
respect
mani
modul
type
ifn
efficaci
laiv
problemat
recent
year
assess
stimul
type
ifn
gene
could
repres
potenti
biomark
respons
laiv
bucasa
colleagu
evalu
gene
express
multipl
time
point
vaccin
healthi
young
men
tiv
note
mark
regul
gene
express
ifn
signal
regul
antigen
process
present
gene
within
h
vaccin
abl
defin
gene
express
signatur
correl
magnitud
antibodi
respons
anoth
studi
gene
profil
predict
antibodi
respons
day
influenza
vaccin
young
older
adult
develop
notabl
predict
gene
young
old
well
subgroup
subject
diabet
suggest
similar
pathway
involv
despit
differ
age
underli
medic
condit
addit
transcript
profil
use
signatur
blood
associ
b
cell
memori
respons
vaccin
studi
older
middl
age
adult
vaccin
tiv
includ
antigen
metabol
cell
migrationadhes
map
kinas
cell
gene
correl
peak
memori
b
cell
elispot
final
studi
subject
vaccin
sever
season
predict
signatur
nine
gene
three
gene
modul
significantli
associ
magnitud
serum
antibodi
respons
fig
interestingli
contrast
previou
studi
signatur
distinct
younger
cohort
exampl
inflammatori
gene
associ
better
respons
young
wors
respons
elderli
summari
gene
express
studi
could
use
evalu
new
vaccin
develop
predictor
vaccin
respons
differ
subgroup
patient
base
age
diseas
state
allow
individu
vaccin
regimen
molecular
analysi
respiratori
virus
host
respons
infect
vaccin
transform
understand
ubiquit
pathogen
abil
accur
diagnosi
viral
infect
impact
patient
care
also
chang
percept
burden
diseas
popul
effect
transcript
profil
blood
nasal
epithelium
may
provid
therapeut
target
prevent
amelior
ill
well
offer
predictor
sever
diseas
